Sphingosine Kinase 1 Deficiency in Smooth Muscle Cells Protects against Hypoxia-Mediated Pulmonary Hypertension via YAP1 Signaling
暂无分享,去创建一个
D. Valdez-Jasso | Ming Tang | V. Natarajan | Haiyang Tang | Jiwang Chen | J. Sysol | A. Lockett | Shuangping Zhao | Bing Liu | Weiwen Wu | Longshuang Huang | R. Machado | Yifan Wang | Raheel Khan | S. Haider | Daniela Velez Rendon | Raheel Khan | Nicholas Felesena | Y. Bai | Yang Bai
[1] Qingting Wang,et al. S1P induces proliferation of pulmonary artery smooth muscle cells by promoting YAP-induced Notch3 expression and activation , 2021, The Journal of biological chemistry.
[2] Qingting Wang,et al. Activation of yes‐associated protein mediates sphingosine‐1‐phosphate–induced proliferation and migration of pulmonary artery smooth muscle cells and its potential mechanisms , 2020, Journal of cellular physiology.
[3] D. Kamp,et al. Sphingosine Kinase 1/S1P Signaling Contributes to Pulmonary Fibrosis by Activating Hippo/YAP Pathway and Mitochondrial Reactive Oxygen Species in Lung Fibroblasts , 2020, International journal of molecular sciences.
[4] Qingting Wang,et al. Inhibition of Siah2 ubiquitin ligase ameliorates monocrotaline-induced pulmonary arterial remodeling through inactivation of YAP. , 2019, Life sciences.
[5] Yan-ting Zhu,et al. Sphingosine-1-phosphate induces airway smooth muscle cell proliferation, migration, and contraction by modulating Hippo signaling effector YAP. , 2018, American journal of physiology. Lung cellular and molecular physiology.
[6] P. Hoodless,et al. S1P Stimulates Proliferation by Upregulating CTGF Expression through S1PR2-Mediated YAP Activation , 2018, Molecular Cancer Research.
[7] S. Comhair,et al. Micro-RNA-1 is decreased by hypoxia and contributes to the development of pulmonary vascular remodeling via regulation of sphingosine kinase 1. , 2018, American journal of physiology. Lung cellular and molecular physiology.
[8] X. Varelas,et al. Arterial stiffness induces remodeling phenotypes in pulmonary artery smooth muscle cells via YAP/TAZ-mediated repression of cyclooxygenase-2. , 2017, American journal of physiology. Lung cellular and molecular physiology.
[9] R. Dweik,et al. Nicotinamide Phosphoribosyltransferase Promotes Pulmonary Vascular Remodeling and Is a Therapeutic Target in Pulmonary Arterial Hypertension , 2017, Circulation.
[10] Neil J Kelly,et al. HIPPO-Integrin-linked Kinase Cross-Talk Controls Self-Sustaining Proliferation and Survival in Pulmonary Hypertension. , 2016, American journal of respiratory and critical care medicine.
[11] J. Loscalzo,et al. Vascular stiffness mechanoactivates YAP/TAZ-dependent glutaminolysis to drive pulmonary hypertension. , 2016, The Journal of clinical investigation.
[12] S. Joshi,et al. Sphingosine-1-Phosphate is Involved in the Occlusive Arteriopathy of Pulmonary Arterial Hypertension , 2016, Pulmonary circulation.
[13] R. Machado,et al. PDGF induces SphK1 expression via Egr-1 to promote pulmonary artery smooth muscle cell proliferation. , 2016, American journal of physiology. Cell physiology.
[14] Wang Wang,et al. Leptin knockout attenuates hypoxia-induced pulmonary arterial hypertension by inhibiting proliferation of pulmonary arterial smooth muscle cells. , 2015, Translational research : the journal of laboratory and clinical medicine.
[15] Yu Lu,et al. Matrix Remodeling Promotes Pulmonary Hypertension through Feedback Mechanoactivation of the YAP/TAZ-miR-130/301 Circuit. , 2015, Cell reports.
[16] J. Garcia,et al. The sphingosine kinase 1/sphingosine-1-phosphate pathway in pulmonary arterial hypertension. , 2014, American journal of respiratory and critical care medicine.
[17] I. Noth,et al. Targeting sphingosine kinase 1 attenuates bleomycin‐induced pulmonary fibrosis , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[18] G. Bonamy,et al. Identification of serum-derived sphingosine-1-phosphate as a small molecule regulator of YAP. , 2012, Chemistry & biology.
[19] Eugene Y. Kim,et al. Sphingosine-1-phosphate produced by sphingosine kinase 1 promotes breast cancer progression by stimulating angiogenesis and lymphangiogenesis. , 2012, Cancer research.
[20] J. Westwick,et al. A novel murine model of severe pulmonary arterial hypertension. , 2011, American journal of respiratory and critical care medicine.
[21] Yunchao Su,et al. Calpain mediates pulmonary vascular remodeling in rodent models of pulmonary hypertension, and its inhibition attenuates pathologic features of disease. , 2011, The Journal of clinical investigation.
[22] J. Garcia,et al. Intracellular Generation of Sphingosine 1-Phosphate in Human Lung Endothelial Cells , 2007, Journal of Biological Chemistry.
[23] J. Yuan,et al. Pathogenesis of pulmonary arterial hypertension: the need for multiple hits. , 2005, Circulation.
[24] J. Downward,et al. Akt phosphorylates the Yes-associated protein, YAP, to induce interaction with 14-3-3 and attenuation of p73-mediated apoptosis. , 2003, Molecular cell.
[25] S. Spiegel,et al. Sphingosine Kinase Expression Increases Intracellular Sphingosine-1-Phosphate and Promotes Cell Growth and Survival , 1999, The Journal of cell biology.
[26] B. Marshall,et al. Pulmonary artery NADPH-oxidase is activated in hypoxic pulmonary vasoconstriction. , 1996, American journal of respiratory cell and molecular biology.